Hopp til hovedinnhold

Panikklidelse

Sist oppdatert: Sist revidert:
Sist revidert av:

Definisjon:
Flere, uventede, plutselige og ofte uforklarlige panikkanfall med bl.a. hjertebank, skjelving, lufthunger, svimmelhet og brystsmerter som typisk fører til angst for nye anfall og livsforstyrrende unngåelsesatferd. Ikke sjelden opplever pasienten dødsangst
Forekomst:
Livstidsprevalensen for panikklidelse er 1-5%, mens nesten 1 av 3 vil oppleve ett panikkanfall. Tilstanden forekommer dobbelt så hyppig blant kvinner
Symptomer:
Kortvarige anfall (5-30 min) der vedkommende plutselig og tilsynelatende uten grunn blir redd med symptomer på adrenerg stimulering
Funn:
Normale kliniske funn utenfor anfall. Funn som kan tilskrives somatisk adrenerg stimulering under anfall
Diagnostikk:
Ingen tilleggsundersøkelser er av diagnostisk verdi
Behandling:
Kognitiv terapi med eksponering er den best dokumenterte behandlingen. Psykodynamisk terapi, psykologisk støttebehandling og forklaring av anfallsopplevelser samt antidepressiva kan være nyttig. Terapi kan løse panikkproblemene hos 80-90%
  1. BMJ Best Practice: Panic disorder. Nettside besøkt 05.03.19. bestpractice.bmj.com  
  2. Malt U, Andressen OA, Malt EA, Melle I, Årsland D (red). Lærebok i psykiatri (s. 294). Oslo: Gyldendal akademisk, 2018.
  3. Teismann T et al. Suicidal ideation in primary care patients suffering from panic disorder with or without agoraphobia. BMC Psychiatry 2018; 18: 305. pmid:30249220 PubMed  
  4. Johnson J, Weissman MM, Klerman GL. Panic disorder, comorbidity, and suicide attempts. Arch Gen Psychiatry 1990; 47: 805-8. pmid:2393338 PubMed  
  5. Kessler RC, Chiu WT, Jin R, et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63: 415-24. pmid:16585471 PubMed  
  6. Ham P, Waters DB, Oliver MN. Treatment of panic disorder. Am Fam Physician 2005; 71: 733-9. PubMed  
  7. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001 Oct. 158(10):1568-78.
  8. Schumacher J, Kristensen AS, Wendland JR, Nöthen MM, Mors O, McMahon FJ, The genetics of panic disorder. J Med Genet 2011;48(6): 361-8 PubMed  
  9. Gorman JM, Ken JM, Sullivan GM, Coplan JD. Neuroanatomic hypothesis of panic disorder, revised. Am J Psychiatry 2000; 157: 493-505. American Journal of Psychiatry  
  10. Abelson JL, Khan S, Liberzon I, Young EA.. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety 2007; 24: 66-76. pmid:16845643 PubMed  
  11. Kaufman J, Charney D. Comorbidity of mood and anxiety disorders. Depress Anxiety 2000; 12(suppl 1): 69-76.
  12. Leskin GA, Sheikh JI. Lifetime trauma history and panic disorder: findings from the National Comorbidity Survey. J Anxiety Disord. 2002;16:599-603. PubMed  
  13. WHO: ICD-11 for Mortality and Morbidity Statistics (December 2018). 6B01 Panic disorder. Nettsiden besøkt 05.03.19. icd.who.int  
  14. Herr NR, Williams JW Jr, Benjamin S, et al. Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review. JAMA. 2014;312(1):78-84. doi: 10.1001/jama.2014.5950 DOI  
  15. Craske MG, Tsao JC. Assessment and treatment of nocturnal panic attacks. Sleep Med Rev 2005; 9: 173-84. pmid:15893248 PubMed  
  16. Stein MB, Roy-Byrne PP, McQuaid JR, et al. Development of a brief diagnostic screen for panic disorder in primary care. Psychosom Med 1999; 61: 359-64. PubMed  
  17. Barr Taylor C. Panic disorder. BMJ 2006; 332: 951-5. PubMed  
  18. Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta‐analysis. Cochrane Database of Systematic Reviews 2016, Issue 4. Art. No.: CD011004. DOI: 10.1002/14651858.CD011004.pub2. DOI  
  19. Imai H, Tajika A, Chen P, Pompoli A, Furukawa TA. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. Cochrane Database of Systematic Reviews 2016, Issue 10. Art. No.: CD011170. DOI: 10.1002/14651858.CD011170.pub2. DOI  
  20. Otto MW, Tuby KS, Gould RA, McLean RY, Pollack MH. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry 2001; 158: 1989-92. American Journal of Psychiatry  
  21. Bakker A, van Balkom AJ, Spinhoven P. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand 2002; 106: 163-7. PubMed  
  22. Bighelli I, Castellazzi M, Cipriani A, Girlanda F, Guaiana G, Koesters M, Turrini G, Furukawa TA, Barbui C. Antidepressants versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews 2018, Issue 4. Art. No.: CD010676. DOI: 10.1002/14651858.CD010676.pub2 DOI  
  23. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Panic Disorder and Agoraphobia. Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia. Aust N Z J Psychiatry 2003; 37: 642-56. PubMed  
  24. Craske MG, Golinelli D, Stein MB, Roy-Byrne P, Bystritsky A, Sherbourne C. Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting? Psychol Med 2005; 35: 1645-54. PubMed  
  25. Olthuis JV, Watt MC, Bailey K, Hayden JA, Stewart SH. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database of Systematic Reviews 2016, Issue 3. Art. No.: CD011565. DOI: 10.1002/14651858.CD011565.pub2. DOI  
  26. Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord 2005; 88: 27-45. PubMed  
  27. Westen D, Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. J Consult Clin Psychol 2001; 69: 875-99. PubMed  
  28. Kenardy JA, Dow MG, Johnston DW, Newman MG, Thomson A, Taylor CB. A comparison of delivery methods of cognitive-behavioral therapy for panic disorder: an international multicenter trial. J Consult Clin Psychol 2003; 71: 1068-75. PubMed  
  29. Katon WJ. Panic disorder. N Engl J Med 2006; 354: 2360-7. PubMed  
  30. Virtual reality i behandling av ångestsyndrom. SBU 2021 www.sbu.se  
  31. de Vries YA, Roest AM, Burgerhof JGM, de Jonge P. Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: An individual patient data meta-analysis. Depress Anxiety 2018; 35: 515-522. pmid:29659102 PubMed  
  32. Otto MW, Tuby KS, Gould RA, McLean RY, Pollack MH. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry 2001; 158: 1989-92. American Journal of Psychiatry  
  33. Chawla N, Anothaisintawee T, Charoenrungrueangchai K, et al. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials. BMJ 2022; 376: e066084. pmid:35045991 PubMed  
  34. Susman J, Klee B. The role of high-potency benzodiazepines in the treatment of panic disorder. Prim Care Companion J Clin Psychiatry 2005; 7: 5-11. PubMed  
  35. Breilmann J, Girlanda F, Guaiana G et al. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews 2019, Issue 3. Art. No.: CD010677. DOI: 10.1002/14651858.CD010677.pub2 DOI  
  36. Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D. Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry 2001; 58: 681-6. PubMed  
  37. Jorm AF, Christensen H, Griffiths KM, Parslow RA, Rodgers B, Blewitt KA. Effectiveness of complementary and self-help treatments for anxiety disorders. Med J Aust 2004; 181: 29-46. PubMed  
  38. Sareen J, Houlahan T, Cox BJ, Asmundson GJ. Anxiety disorders associated with suicidal ideation and suicide attempts in the national comorbidity survey. J Nerv Ment Dis 2005; 193: 450-4. PubMed  
  39. Pilowsky DJ, Olfson M, Gameroff MJ, Wickramaratne P, Blanco C, Feder A, et al. Panic disorder and suicidal ideation in primary care. Depress Anxiety 2006; 23: 11-6. PubMed  
  40. Machado S et al. Panic disorder and cardiovascular diseases: an overview. Int Rev Psychiatry 2017; 29: 436-444. pmid:28893114 PubMed  
  41. Fava GA, Zielezny M, Savron G, Grandi S. Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry. 1995;166(1):87‐92. doi:10.1192/bjp.166.1.87 DOI  
  42. Ballenger JC, Pecknold J, Rickels K, Sellers EM. Medication discontinuation in panic disorder. J Clin Psychiatry. 1993;54 Suppl:15‐24.
  43. Bruce SE, Yonkers KA, Otto MW, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179-87. American Journal of Psychiatry  
  44. Player MS, Peterson LE, Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med 2011;41(4): 365-77 PubMed  
  • Ola Nordviste, psykiater

Tidligere fagmedarbeidere

  • Olav Thorsen, spesialist allmennmedisin, Klubbgaten legesenter, Stavanger
  • K Gunnar Götestam, professor, Psykiatrisk institutt, Norges teknisk-naturvitenskapelige universitet, Trondheim